JPWO2022114128A1 - - Google Patents

Info

Publication number
JPWO2022114128A1
JPWO2022114128A1 JP2022541798A JP2022541798A JPWO2022114128A1 JP WO2022114128 A1 JPWO2022114128 A1 JP WO2022114128A1 JP 2022541798 A JP2022541798 A JP 2022541798A JP 2022541798 A JP2022541798 A JP 2022541798A JP WO2022114128 A1 JPWO2022114128 A1 JP WO2022114128A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022541798A
Other languages
Japanese (ja)
Other versions
JP7239068B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022114128A1 publication Critical patent/JPWO2022114128A1/ja
Application granted granted Critical
Publication of JP7239068B2 publication Critical patent/JP7239068B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
JP2022541798A 2020-11-26 2021-11-26 立体的細胞組織の製造方法及び立体的細胞組織 Active JP7239068B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020196310 2020-11-26
JP2020196310 2020-11-26
PCT/JP2021/043393 WO2022114128A1 (ja) 2020-11-26 2021-11-26 立体的細胞組織の製造方法及び立体的細胞組織

Publications (2)

Publication Number Publication Date
JPWO2022114128A1 true JPWO2022114128A1 (enrdf_load_stackoverflow) 2022-06-02
JP7239068B2 JP7239068B2 (ja) 2023-03-14

Family

ID=81754428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022541798A Active JP7239068B2 (ja) 2020-11-26 2021-11-26 立体的細胞組織の製造方法及び立体的細胞組織

Country Status (5)

Country Link
US (1) US20230287356A1 (enrdf_load_stackoverflow)
EP (1) EP4253528A4 (enrdf_load_stackoverflow)
JP (1) JP7239068B2 (enrdf_load_stackoverflow)
CN (1) CN116457458A (enrdf_load_stackoverflow)
WO (1) WO2022114128A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250036837A (ko) * 2022-07-14 2025-03-14 오리즈루 세라퓨틱스 가부시키가이샤 세포 이식용의 피브린 겔 시트
WO2025023216A1 (ja) * 2023-07-27 2025-01-30 Ｔｏｐｐａｎホールディングス株式会社 立体的細胞組織の製造方法及び立体的細胞組織
WO2025143240A1 (ja) * 2023-12-28 2025-07-03 Ｔｏｐｐａｎホールディングス株式会社 細胞構造体を製造する方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017146124A1 (ja) * 2016-02-22 2017-08-31 国立大学法人大阪大学 立体的細胞組織の製造方法
WO2020203579A1 (ja) * 2019-04-01 2020-10-08 凸版印刷株式会社 三次元組織体及びその製造方法並びに細胞含有組成物の製造方法
WO2021100709A1 (ja) * 2019-11-19 2021-05-27 凸版印刷株式会社 細胞構造体及びその製造方法並びに被験物質の肝毒性の評価方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009017267A1 (en) * 2007-08-01 2009-02-05 Regenprime Co., Ltd. Method for differenciating mesenchymal stem cell and culturing chondrocytes using alginate coated fibrin/ha composite scaffold
WO2012111000A1 (en) * 2011-02-14 2012-08-23 Technion Research And Development Foundation Ltd Tissue engineering construct comprising fibrin
JP7176727B2 (ja) * 2018-08-28 2022-11-22 国立大学法人大阪大学 三次元心筋組織の製造方法
JP2020196310A (ja) 2019-05-31 2020-12-10 市光工業株式会社 車両用灯具
JPWO2023017800A1 (enrdf_load_stackoverflow) * 2021-08-11 2023-02-16

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017146124A1 (ja) * 2016-02-22 2017-08-31 国立大学法人大阪大学 立体的細胞組織の製造方法
WO2020203579A1 (ja) * 2019-04-01 2020-10-08 凸版印刷株式会社 三次元組織体及びその製造方法並びに細胞含有組成物の製造方法
WO2021100709A1 (ja) * 2019-11-19 2021-05-27 凸版印刷株式会社 細胞構造体及びその製造方法並びに被験物質の肝毒性の評価方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ACTA BIOMATERIALIA, 2019.03.01, VOL.95, PP.348-356, JPN6020017109, ISSN: 0004939638 *
ANGIOGENESIS, 2012, VOL.15, PP.253-264, JPN6020017113, ISSN: 0004939639 *

Also Published As

Publication number Publication date
US20230287356A1 (en) 2023-09-14
JP7239068B2 (ja) 2023-03-14
EP4253528A4 (en) 2024-10-30
CN116457458A (zh) 2023-07-18
EP4253528A1 (en) 2023-10-04
WO2022114128A1 (ja) 2022-06-02

Similar Documents

Publication Publication Date Title
BR112023005462A2 (enrdf_load_stackoverflow)
BR112023012656A2 (enrdf_load_stackoverflow)
BR112021014123A2 (enrdf_load_stackoverflow)
BR112023009656A2 (enrdf_load_stackoverflow)
BR112022009896A2 (enrdf_load_stackoverflow)
JPWO2022114128A1 (enrdf_load_stackoverflow)
BR112023008622A2 (enrdf_load_stackoverflow)
JPWO2023017800A1 (enrdf_load_stackoverflow)
BR112022024743A2 (enrdf_load_stackoverflow)
BR112022026905A2 (enrdf_load_stackoverflow)
BR112023011738A2 (enrdf_load_stackoverflow)
BR112023004146A2 (enrdf_load_stackoverflow)
BR112023006729A2 (enrdf_load_stackoverflow)
BR102021018859A2 (enrdf_load_stackoverflow)
BR102021015500A2 (enrdf_load_stackoverflow)
BR112021017747A2 (enrdf_load_stackoverflow)
JPWO2023120573A1 (enrdf_load_stackoverflow)
BR112023016292A2 (enrdf_load_stackoverflow)
BR112023011610A2 (enrdf_load_stackoverflow)
BR112023011539A2 (enrdf_load_stackoverflow)
BR112023008976A2 (enrdf_load_stackoverflow)
BR102021020147A2 (enrdf_load_stackoverflow)
BR102021018926A2 (enrdf_load_stackoverflow)
BR102021018167A2 (enrdf_load_stackoverflow)
BR102021017576A2 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220706

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220706

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221024

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230131

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230213

R150 Certificate of patent or registration of utility model

Ref document number: 7239068

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150